Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/305% below fair value
$18.27−0.20 (-1.08%)
Close on Nov 17, 2026Market cap $890.78MP/E –Yield –
Artivion operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Artivion's operating cash flow for the twelve months ending Jun 30, 2026 was $41.71M, up 112.2% year over year. For fiscal 2025 it was $39.88M, up 79.3% from the year before. Over ten years it grew 13.3% a year on average. The highest annual figure on record is $39.88M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.88M | +79.3% |
| FY2024 | Dec 31, 2024 | $22.24M | +18.1% |
| FY2023 | Dec 31, 2023 | $18.83M | – |
| FY2022 | Dec 31, 2022 | -$5.15M | – |
| FY2021 | Dec 31, 2021 | -$2.59M | -120.9% |
| FY2020 | Dec 31, 2020 | $12.37M | -21.8% |
| FY2019 | Dec 31, 2019 | $15.83M | +60.2% |
| FY2018 | Dec 31, 2018 | $9.88M | -8.5% |
| FY2017 | Dec 31, 2017 | $10.80M | -45.2% |
| FY2016 | Dec 31, 2016 | $19.72M | +72.3% |
| FY2015 | Dec 31, 2015 | $11.44M | +40.9% |
| FY2014 | Dec 31, 2014 | $8.12M | -51.6% |
| FY2013 | Dec 31, 2013 | $16.77M | -11.7% |
| FY2012 | Dec 31, 2012 | $18.99M | +13.4% |
| FY2011 | Dec 31, 2011 | $16.75M | -19.6% |
| FY2010 | Dec 31, 2010 | $20.84M | +25.7% |
| FY2009 | Dec 31, 2009 | $16.57M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.27M | -108.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.15M | – |
| Q4 FY2025 | Dec 31, 2025 | $19.56M | +92.9% |
| Q3 FY2025 | Sep 30, 2025 | $22.26M | +94.3% |
| Q2 FY2025 | Jun 30, 2025 | $15.01M | +144.7% |
| Q1 FY2025 | Mar 31, 2025 | -$16.95M | – |
| Q4 FY2024 | Dec 31, 2024 | $10.14M | -6.4% |
| Q3 FY2024 | Sep 30, 2024 | $11.46M | +58.4% |
| Q2 FY2024 | Jun 30, 2024 | $6.14M | -11.2% |
| Q1 FY2024 | Mar 31, 2024 | -$5.49M | – |
| Q4 FY2023 | Dec 31, 2023 | $10.84M | – |
| Q3 FY2023 | Sep 30, 2023 | $7.23M | +81.9% |
| Q2 FY2023 | Jun 30, 2023 | $6.91M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.15M | – |
| Q4 FY2022 | Dec 31, 2022 | -$217.00K | -130.3% |
| Q3 FY2022 | Sep 30, 2022 | $3.98M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.31M | -414.1% |
| Q1 FY2022 | Mar 31, 2022 | -$598.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $716.00K | -86.9% |
| Q3 FY2021 | Sep 30, 2021 | -$2.91M | -137.9% |
| Q2 FY2021 | Jun 30, 2021 | $2.65M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.04M | -215.3% |
| Q4 FY2020 | Dec 31, 2020 | $5.45M | +414.2% |
| Q3 FY2020 | Sep 30, 2020 | $7.68M | -40.3% |
| Q2 FY2020 | Jun 30, 2020 | -$3.40M | -555.1% |
| Q1 FY2020 | Mar 31, 2020 | $2.64M | +127.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.06M | -89.9% |
| Q3 FY2019 | Sep 30, 2019 | $12.86M | +54.6% |
| Q2 FY2019 | Jun 30, 2019 | $746.00K | -2.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.16M | – |
| Q4 FY2018 | Dec 31, 2018 | $10.52M | +76.0% |
| Q3 FY2018 | Sep 30, 2018 | $8.32M | +196.7% |
| Q2 FY2018 | Jun 30, 2018 | $767.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.73M | -351.4% |
| Q4 FY2017 | Dec 31, 2017 | $5.98M | +18.5% |
| Q3 FY2017 | Sep 30, 2017 | $2.80M | -68.3% |
| Q2 FY2017 | Jun 30, 2017 | -$1.85M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.87M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.05M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.84M | – |
See a number that looks wrong?